This statistic depicts the number of currently active novel disease-modifying clinical trials for Alzheimer's disease drugs globally as of February 2019, by phase. At that time there were 34 active clinical trials for novel disease-modifying Alzheimer's drugs in phase II.
Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*
* Twelve programs listed as “Ex-US” in the Biomedtracker database are included here by phase based on independent research of company websites. This “Ex-US” listing implies the companies have not yet intended to seek FDA approval. No NDA/BLA filings were active for Alzheimer’s Disease as of February 28, 2019. Only novel approaches with disease modifying potential in Alzheimer’s disease are shown.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Biotechnology Innovation Organization. (May 14, 2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph]. In Statista. Retrieved February 07, 2025, from https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed
Biotechnology Innovation Organization. "Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*." Chart. May 14, 2019. Statista. Accessed February 07, 2025. https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed
Biotechnology Innovation Organization. (2019). Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase*. Statista. Statista Inc.. Accessed: February 07, 2025. https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed
Biotechnology Innovation Organization. "Total Number of Currently Active Global Novel Disease-modifying Clinical Trials for Alzheimer's Disease Drugs in Early 2019, by Phase*." Statista, Statista Inc., 14 May 2019, https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed
Biotechnology Innovation Organization, Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* Statista, https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed (last visited February 07, 2025)
Total number of currently active global novel disease-modifying clinical trials for Alzheimer's disease drugs in early 2019, by phase* [Graph], Biotechnology Innovation Organization, May 14, 2019. [Online]. Available: https://www.statista.com/statistics/1029540/active-alzheimers-disease-modifying-drug-global-clinical-trials-by-phase/?__sso_cookie_checker=failed